Shifa Biomedical is a drug discovery company that develops drugs for the treatment of cardiovascular disease.
Shifa Biomedical Corporation is a drug discovery company in Malvern Pennsylvania. It is a privately-held biopharmaceutical company dedicated to the cost-effective development of drugs for the treatment of cardiovascular disease.Incorporated in 2006, Shifa has recognized expertise for the discovery of small molecule drugs, including pharmaceutical experience guided by biochemical, cell-based, and virtual screening. Shifa scientists exploit molecular biology, biochemistry, crystallography and medicinal, computational, and combinatorial chemistry. Shifa is led by a highly experienced team of scientists with extensive expertise in early-stage drug discovery.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 12, 2021 | Seed | — | 1 | Xontogeny | — | Detail |